The commercial license will become effective upon completion of the transition of commercial rights from Biogen back to Samsung Bioepis, which is expected to be completed by the end of 2025.
Designed to celebrate the connection between skin care and self care, the initiative focuses on the perspective of how skin care can be seen as a self-affirmation.